Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

J Henry Fuchs


  • President, Worldwide R&d at Biomarin Pharmaceutical Inc (BMRN), 2020-03-25
  • at Mirati Therapeutics Inc. (MRTX), 2020-01-08
  • Director at Genomic Health Inc (GHDX), 2019-11-15
  • Director at Ardea Biosciences Inc. (RDEA), 2012-06-20
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
BMRN $87.86 5,932 Officer 124,536 2019-03-25 Filing
BMRN $94.09 9,597 Officer 136,304 2019-03-18 Filing
BMRN $95.00 2,196 Officer 142,504 2019-03-04 Filing
GHDX $79.80 521 Director 6,332 2019-02-25 Filing
GHDX $78.88 3,000 Director 6,853 2019-02-25 Filing